| Symbol |
Name |
|
ABAT
|
4-aminobutyrate aminotransferase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABI1
|
abl-interactor 1
|
|
ABI2
|
abl-interactor 2
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACLY
|
ATP citrate lyase
|
|
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase
|
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTG1
|
actin gamma 1
|
|
ACTN1
|
actinin, alpha 1
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
ADRBK2
|
adrenergic, beta, receptor kinase 2
|
|
AFF2
|
AF4/FMR2 family, member 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGPAT6
|
1-acylglycerol-3-phosphate O-acyltransferase 6
|
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHNAK
|
AHNAK nucleoprotein
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM2
|
apoptosis-inducing factor, mitochondrion-associated, 2
|
|
AIRE
|
autoimmune regulator
|
|
AK2
|
adenylate kinase 2
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANOS1
|
anosmin 1
|
|
AOC3
|
amine oxidase, copper containing 3
|
|
APBB1IP
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
|
|
APC
|
adenomatous polyposis coli
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOBR
|
apolipoprotein B receptor
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APOL1
|
apolipoprotein L, 1
|
|
APOO
|
apolipoprotein O
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AR
|
androgen receptor
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARHGAP5
|
Rho GTPase activating protein 5
|
|
ARHGEF11
|
Rho guanine nucleotide exchange factor (GEF) 11
|
|
ARHGEF16
|
Rho guanine nucleotide exchange factor (GEF) 16
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARL13B
|
ADP-ribosylation factor-like 13B
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASAP3
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
|
|
ASF1A
|
anti-silencing function 1A histone chaperone
|
|
ASF1B
|
anti-silencing function 1B histone chaperone
|
|
ASNA1
|
arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)
|
|
ASPN
|
asporin
|
|
ATF4
|
activating transcription factor 4
|
|
ATF5
|
activating transcription factor 5
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
ATP2A3
|
ATPase, Ca++ transporting, ubiquitous
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN2
|
ataxin 2
|
|
AUP1
|
ancient ubiquitous protein 1
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
B2M
|
beta-2-microglobulin
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BLNK
|
B-cell linker
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP3
|
bone morphogenetic protein 3
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BMS1
|
BMS1 ribosome biogenesis factor
|
|
BOK
|
BCL2-related ovarian killer
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTG2
|
BTG family, member 2
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1
|
|
C5AR1
|
complement component 5a receptor 1
|
|
C8ORF4
|
chromosome 8 open reading frame 4
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CADM3
|
cell adhesion molecule 3
|
|
CALR
|
calreticulin
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast)
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPN10
|
calpain 10
|
|
CAPN3
|
calpain 3, (p94)
|
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CASZ1
|
castor zinc finger 1
|
|
CBX5
|
chromobox homolog 5
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCHCR1
|
coiled-coil alpha-helical rod protein 1
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNK
|
cyclin K
|
|
CCNT1
|
cyclin T1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD2
|
CD2 molecule
|
|
CD274
|
CD274 molecule
|
|
CD2AP
|
CD2-associated protein
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD69
|
CD69 molecule
|
|
CD7
|
CD7 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD99
|
CD99 molecule
|
|
CDAN1
|
codanin 1
|
|
CDC7
|
cell division cycle 7
|
|
CDC73
|
cell division cycle 73
|
|
CDCA8
|
cell division cycle associated 8
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH23
|
cadherin-related 23
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDON
|
cell adhesion associated, oncogene regulated
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPE
|
centromere protein E, 312kDa
|
|
CENPT
|
centromere protein T
|
|
CENPW
|
centromere protein W
|
|
CEP164
|
centrosomal protein 164kDa
|
|
CEP290
|
centrosomal protein 290kDa
|
|
CEP63
|
centrosomal protein 63kDa
|
|
CERKL
|
ceramide kinase-like
|
|
CERS3
|
ceramide synthase 3
|
|
CERS6
|
ceramide synthase 6
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHD1
|
chromodomain helicase DNA binding protein 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHKA
|
choline kinase alpha
|
|
CHMP1A
|
charged multivesicular body protein 1A
|
|
CHMP2B
|
charged multivesicular body protein 2B
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CIAO1
|
cytosolic iron-sulfur assembly component 1
|
|
CINP
|
cyclin-dependent kinase 2 interacting protein
|
|
CLASP1
|
cytoplasmic linker associated protein 1
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CLOCK
|
clock circadian regulator
|
|
CLP1
|
cleavage and polyadenylation factor I subunit 1
|
|
CMTM7
|
CKLF-like MARVEL transmembrane domain containing 7
|
|
CMYA5
|
cardiomyopathy associated 5
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COIL
|
coilin
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPE
|
carboxypeptidase E
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CST3
|
cystatin C
|
|
CST6
|
cystatin E/M
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTTN
|
cortactin
|
|
CUL1
|
cullin 1
|
|
CUL2
|
cullin 2
|
|
CUL7
|
cullin 7
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2W1
|
cytochrome P450, family 2, subfamily W, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP51A1
|
cytochrome P450, family 51, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
CYTL1
|
cytokine-like 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides
|
|
DAXX
|
death-domain associated protein
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFB103B
|
defensin, beta 103B
|
|
DERL2
|
derlin 2
|
|
DERL3
|
derlin 3
|
|
DES
|
desmin
|
|
DGAT2
|
diacylglycerol O-acyltransferase 2
|
|
DHX9
|
DEAH (Asp-Glu-Ala-His) box helicase 9
|
|
DIAPH1
|
diaphanous-related formin 1
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLG5
|
discs, large homolog 5 (Drosophila)
|
|
DLGAP3
|
discs, large (Drosophila) homolog-associated protein 3
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DOT1L
|
DOT1-like histone H3K79 methyltransferase
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSG1
|
desmoglein 1
|
|
DSG3
|
desmoglein 3
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYNLT1
|
dynein, light chain, Tctex-type 1
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
DYSF
|
dysferlin
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
E2F5
|
E2F transcription factor 5, p130-binding
|
|
E2F7
|
E2F transcription factor 7
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EHD2
|
EH-domain containing 2
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF3F
|
eukaryotic translation initiation factor 3, subunit F
|
|
EIF4A2
|
eukaryotic translation initiation factor 4A2
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF6
|
eukaryotic translation initiation factor 6
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELOVL5
|
ELOVL fatty acid elongase 5
|
|
EMD
|
emerin
|
|
EME1
|
essential meiotic structure-specific endonuclease 1
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA3
|
EPH receptor A3
|
|
EPHA7
|
EPH receptor A7
|
|
EPHB1
|
EPH receptor B1
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB4
|
EPH receptor B4
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERF
|
Ets2 repressor factor
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
|
FAM96A
|
family with sequence similarity 96, member A
|
|
FAM96B
|
family with sequence similarity 96, member B
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASN
|
fatty acid synthase
|
|
FBN1
|
fibrillin 1
|
|
FBXL5
|
F-box and leucine-rich repeat protein 5
|
|
FBXO42
|
F-box protein 42
|
|
FBXW8
|
F-box and WD repeat domain containing 8
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1
|
|
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1
|
|
FFAR1
|
free fatty acid receptor 1
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF3
|
fibroblast growth factor 3
|
|
FLG
|
filaggrin
|
|
FLNA
|
filamin A, alpha
|
|
FLOT2
|
flotillin 2
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FMN2
|
formin 2
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FNBP1
|
formin binding protein 1
|
|
FNBP1L
|
formin binding protein 1-like
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXA1
|
forkhead box A1
|
|
FOXO1
|
forkhead box O1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FOXQ1
|
forkhead box Q1
|
|
FRMD3
|
FERM domain containing 3
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
FXN
|
frataxin
|
|
FYB
|
FYN binding protein
|
|
FZD6
|
frizzled class receptor 6
|
|
FZD7
|
frizzled class receptor 7
|
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GALNT1
|
polypeptide N-acetylgalactosaminyltransferase 1
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GBA
|
glucosidase, beta, acid
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF15
|
growth differentiation factor 15
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIPC1
|
GIPC PDZ domain containing family, member 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLO1
|
glyoxalase I
|
|
GLRX2
|
glutaredoxin 2
|
|
GNAI3
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GOLGA4
|
golgin A4
|
|
GOSR1
|
golgi SNAP receptor complex member 1
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GUCY2C
|
guanylate cyclase 2C
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAPLN1
|
hyaluronan and proteoglycan link protein 1
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC5
|
histone deacetylase 5
|
|
HDAC7
|
histone deacetylase 7
|
|
HERPUD1
|
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HESX1
|
HESX homeobox 1
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
|
HFE
|
hemochromatosis
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNMT
|
histamine N-methyltransferase
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HOOK1
|
hook microtubule-tethering protein 1
|
|
HOXA10
|
homeobox A10
|
|
HOXA9
|
homeobox A9
|
|
HOXD13
|
homeobox D13
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRG
|
histidine-rich glycoprotein
|
|
HS3ST3B1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
HYAL1
|
hyaluronoglucosaminidase 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGSF8
|
immunoglobulin superfamily, member 8
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL17RA
|
interleukin 17 receptor A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL3
|
interleukin 3
|
|
IL31
|
interleukin 31
|
|
IL31RA
|
interleukin 31 receptor A
|
|
IL33
|
interleukin 33
|
|
IL37
|
interleukin 37
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IMMT
|
inner membrane protein, mitochondrial
|
|
INF2
|
inverted formin, FH2 and WH2 domain containing
|
|
INHA
|
inhibin, alpha
|
|
INPP5E
|
inositol polyphosphate-5-phosphatase, 72 kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF8
|
interferon regulatory factor 8
|
|
ISCU
|
iron-sulfur cluster assembly enzyme
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB5
|
integrin, beta 5
|
|
ITM2B
|
integral membrane protein 2B
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
ITSN1
|
intersectin 1 (SH3 domain protein)
|
|
JADE1
|
jade family PHD finger 1
|
|
JAK2
|
Janus kinase 2
|
|
JPH2
|
junctophilin 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNN2
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KHSRP
|
KH-type splicing regulatory protein
|
|
KIAA0101
|
KIAA0101
|
|
KIAA0391
|
KIAA0391
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF15
|
Kruppel-like factor 15
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KNSTRN
|
kinetochore-localized astrin/SPAG5 binding protein
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LCN2
|
lipocalin 2
|
|
LCT
|
lactase
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LIMA1
|
LIM domain and actin binding 1
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LMNA
|
lamin A/C
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
LOR
|
loricrin
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPL
|
lipoprotein lipase
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTB4R
|
leukotriene B4 receptor
|
|
MACC1
|
metastasis associated in colon cancer 1
|
|
MACF1
|
microtubule-actin crosslinking factor 1
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MALT1
|
MALT1 paracaspase
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K10
|
mitogen-activated protein kinase kinase kinase 10
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MAX
|
MYC associated factor X
|
|
MBD1
|
methyl-CpG binding domain protein 1
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC3R
|
melanocortin 3 receptor
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCHR1
|
melanin-concentrating hormone receptor 1
|
|
MCM3AP
|
minichromosome maintenance complex component 3 associated protein
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDGA2
|
MAM domain containing glycosylphosphatidylinositol anchor 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED28
|
mediator complex subunit 28
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEIS1
|
Meis homeobox 1
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEOX2
|
mesenchyme homeobox 2
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
METAP2
|
methionyl aminopeptidase 2
|
|
MFN2
|
mitofusin 2
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIAT
|
myocardial infarction associated transcript (non-protein coding)
|
|
MIB2
|
mindbomb E3 ubiquitin protein ligase 2
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR10B
|
microRNA 10b
|
|
MIR122
|
microRNA 122
|
|
MIR129-1
|
microRNA 129-1
|
|
MIR137
|
microRNA 137
|
|
MIR143
|
microRNA 143
|
|
MIR155HG
|
MIR155 host gene
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR199B
|
microRNA 199b
|
|
MIR21
|
microRNA 21
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR24-1
|
microRNA 24-1
|
|
MIR302A
|
microRNA 302a
|
|
MIR30A
|
microRNA 30a
|
|
MIR30C2
|
microRNA 30c-2
|
|
MIR34A
|
microRNA 34a
|
|
MIR373
|
microRNA 373
|
|
MIR494
|
microRNA 494
|
|
MIR520C
|
microRNA 520c
|
|
MIR661
|
microRNA 661
|
|
MIR98
|
microRNA 98
|
|
MIRLET7C
|
microRNA let-7c
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MLH1
|
mutL homolog 1
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MLPH
|
melanophilin
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP17
|
matrix metallopeptidase 17 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOCS3
|
molybdenum cofactor synthesis 3
|
|
MOS
|
v-mos Moloney murine sarcoma viral oncogene homolog
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MRC2
|
mannose receptor, C type 2
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSMB
|
microseminoprotein, beta-
|
|
MST1
|
macrophage stimulating 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUS81
|
MUS81 structure-specific endonuclease subunit
|
|
MXD1
|
MAX dimerization protein 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCS1
|
neuronal calcium sensor 1
|
|
NDC80
|
NDC80 kinetochore complex component
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEK2
|
NIMA-related kinase 2
|
|
NES
|
nestin
|
|
NEU1
|
sialidase 1 (lysosomal sialidase)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
|
NGFR
|
nerve growth factor receptor
|
|
NHEJ1
|
nonhomologous end-joining factor 1
|
|
NIN
|
ninein (GSK3B interacting protein)
|
|
NIPA1
|
non imprinted in Prader-Willi/Angelman syndrome 1
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NLRX1
|
NLR family member X1
|
|
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1
|
|
NMU
|
neuromedin U
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPAT
|
nuclear protein, ataxia-telangiectasia locus
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPS
|
neuropeptide S
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR1D2
|
nuclear receptor subfamily 1, group D, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRP2
|
neuropilin 2
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
NUCB2
|
nucleobindin 2
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NUP155
|
nucleoporin 155kDa
|
|
NXF1
|
nuclear RNA export factor 1
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORC1
|
origin recognition complex, subunit 1
|
|
OSBP
|
oxysterol binding protein
|
|
OSM
|
oncostatin M
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PARD3
|
par-3 family cell polarity regulator
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCDH10
|
protocadherin 10
|
|
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
|
|
PDCD10
|
programmed cell death 10
|
|
PDCD5
|
programmed cell death 5
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE6G
|
phosphodiesterase 6G, cGMP-specific, rod, gamma
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEG10
|
paternally expressed 10
|
|
PER1
|
period circadian clock 1
|
|
PGR
|
progesterone receptor
|
|
PHF8
|
PHD finger protein 8
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PIGK
|
phosphatidylinositol glycan anchor biosynthesis, class K
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PINX1
|
PIN2/TERF1 interacting, telomerase inhibitor 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PKP2
|
plakophilin 2
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G3
|
phospholipase A2, group III
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLEKHA2
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2
|
|
PLK4
|
polo-like kinase 4
|
|
PLTP
|
phospholipid transfer protein
|
|
PMCH
|
pro-melanin-concentrating hormone
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNPLA8
|
patatin-like phospholipase domain containing 8
|
|
POC1B
|
POC1 centriolar protein B
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
POLR3B
|
polymerase (RNA) III (DNA directed) polypeptide B
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU3F2
|
POU class 3 homeobox 2
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRC1
|
protein regulator of cytokinesis 1
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM5
|
PR domain containing 5
|
|
PREX2
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
|
|
PRIMPOL
|
primase and polymerase (DNA-directed)
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCSH
|
protein kinase C substrate 80K-H
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator
|
|
PRLR
|
prolactin receptor
|
|
PRM2
|
protamine 2
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRNP
|
prion protein
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PSEN1
|
presenilin 1
|
|
PSMA6
|
proteasome (prosome, macropain) subunit, alpha type, 6
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSME3
|
proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
|
|
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGFRN
|
prostaglandin F2 receptor inhibitor
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN14
|
protein tyrosine phosphatase, non-receptor type 14
|
|
PTPRF
|
protein tyrosine phosphatase, receptor type, F
|
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1
|
|
PTRF
|
polymerase I and transcript release factor
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALBP1
|
ralA binding protein 1
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RANBP10
|
RAN binding protein 10
|
|
RANBP2
|
RAN binding protein 2
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM10
|
RNA binding motif protein 10
|
|
RBM8A
|
RNA binding motif protein 8A
|
|
RBMY1A1
|
RNA binding motif protein, Y-linked, family 1, member A1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RELN
|
reelin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RHOT1
|
ras homolog family member T1
|
|
RHOT2
|
ras homolog family member T2
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RINT1
|
RAD50 interactor 1
|
|
RNF139
|
ring finger protein 139
|
|
RNF168
|
ring finger protein 168, E3 ubiquitin protein ligase
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPAP3
|
RNA polymerase II associated protein 3
|
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RTTN
|
rotatin
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUSC2
|
RUN and SH3 domain containing 2
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SAA1
|
serum amyloid A1
|
|
SAA2
|
serum amyloid A2
|
|
SAA@
|
serum amyloid A1 cluster
|
|
SALL2
|
spalt-like transcription factor 2
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCML2
|
sex comb on midleg-like 2 (Drosophila)
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SDC1
|
syndecan 1
|
|
SDC3
|
syndecan 3
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SELE
|
selectin E
|
|
SEPT7
|
septin 7
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SESN2
|
sestrin 2
|
|
SETD2
|
SET domain containing 2
|
|
SETDB1
|
SET domain, bifurcated 1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGK3
|
serum/glucocorticoid regulated kinase family, member 3
|
|
SGOL1
|
shugoshin-like 1 (S. pombe)
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2
|
|
SHH
|
sonic hedgehog
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SHOX2
|
short stature homeobox 2
|
|
SIM1
|
single-minded family bHLH transcription factor 1
|
|
SIM2
|
single-minded family bHLH transcription factor 2
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SIX3
|
SIX homeobox 3
|
|
SKIV2L
|
superkiller viralicidic activity 2-like (S. cerevisiae)
|
|
SKP1
|
S-phase kinase-associated protein 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC20A1
|
solute carrier family 20 (phosphate transporter), member 1
|
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2
|
|
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC24A4
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC36A1
|
solute carrier family 36 (proton/amino acid symporter), member 1
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCA5
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
|
|
SMARCD1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1
|
|
SMG1
|
SMG1 phosphatidylinositol 3-kinase-related kinase
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMOC1
|
SPARC related modular calcium binding 1
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SND1
|
staphylococcal nuclease and tudor domain containing 1
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORCS1
|
sortilin-related VPS10 domain containing receptor 1
|
|
SOST
|
sclerostin
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP7
|
Sp7 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR1B
|
small proline-rich protein 1B
|
|
SPTLC1
|
serine palmitoyltransferase, long chain base subunit 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRR
|
serine racemase
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SSRP1
|
structure specific recognition protein 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAB2
|
stabilin 2
|
|
STARD10
|
StAR-related lipid transfer (START) domain containing 10
|
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK26
|
serine/threonine protein kinase 26
|
|
STX18
|
syntaxin 18
|
|
STXBP3
|
syntaxin binding protein 3
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
SYK
|
spleen tyrosine kinase
|
|
TACC3
|
transforming, acidic coiled-coil containing protein 3
|
|
TANK
|
TRAF family member-associated NFKB activator
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS2R9
|
taste receptor, type 2, member 9
|
|
TAX1BP1
|
Tax1 (human T-cell leukemia virus type I) binding protein 1
|
|
TAX1BP3
|
Tax1 (human T-cell leukemia virus type I) binding protein 3
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBKBP1
|
TBK1 binding protein 1
|
|
TBP
|
TATA box binding protein
|
|
TBX2
|
T-box 2
|
|
TBX20
|
T-box 20
|
|
TCF3
|
transcription factor 3
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TEC
|
tec protein tyrosine kinase
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGM2
|
transglutaminase 2
|
|
THAP5
|
THAP domain containing 5
|
|
THBS1
|
thrombospondin 1
|
|
THPO
|
thrombopoietin
|
|
TIMM23
|
translocase of inner mitochondrial membrane 23 homolog (yeast)
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
|
TLN1
|
talin 1
|
|
TLN2
|
talin 2
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TMEM173
|
transmembrane protein 173
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TMTC1
|
transmembrane and tetratricopeptide repeat containing 1
|
|
TMTC2
|
transmembrane and tetratricopeptide repeat containing 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNPO3
|
transportin 3
|
|
TNRC6A
|
trinucleotide repeat containing 6A
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TRA2B
|
transformer 2 beta homolog (Drosophila)
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM25
|
tripartite motif containing 25
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIM37
|
tripartite motif containing 37
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPC7
|
transient receptor potential cation channel, subfamily C, member 7
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSC22D3
|
TSC22 domain family, member 3
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTK
|
TTK protein kinase
|
|
TTN
|
titin
|
|
TUB
|
tubby bipartite transcription factor
|
|
TUBA4A
|
tubulin, alpha 4a
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBB6
|
tubulin, beta 6 class V
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TXN
|
thioredoxin
|
|
TYMS
|
thymidylate synthetase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2
|
|
UBE2B
|
ubiquitin-conjugating enzyme E2B
|
|
UBE2E2
|
ubiquitin-conjugating enzyme E2E 2
|
|
UBE2G2
|
ubiquitin-conjugating enzyme E2G 2
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBQLN2
|
ubiquilin 2
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT8
|
UDP glycosyltransferase 8
|
|
UMOD
|
uromodulin
|
|
UNC13A
|
unc-13 homolog A (C. elegans)
|
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast)
|
|
URM1
|
ubiquitin related modifier 1
|
|
USH1C
|
Usher syndrome 1C (autosomal recessive, severe)
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VCAN
|
versican
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIMP
|
VCP-interacting membrane selenoprotein
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASF2
|
WAS protein family, member 2
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WDPCP
|
WD repeat containing planar cell polarity effector
|
|
WISP3
|
WNT1 inducible signaling pathway protein 3
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WT1
|
Wilms tumor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC6BP1
|
XRCC6 binding protein 1
|
|
YAP1
|
Yes-associated protein 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZMYND19
|
zinc finger, MYND-type containing 19
|
|
ZNF217
|
zinc finger protein 217
|
|
ZNF300
|
zinc finger protein 300
|
|
ZNF711
|
zinc finger protein 711
|
|
ZNF804A
|
zinc finger protein 804A
|
|
ZW10
|
zw10 kinetochore protein
|
